Literature DB >> 21117452

Mechanism of anti-diabetic action, efficacy and safety profile of GII purified from fenugreek (Trigonella foenum-graceum Linn.) seeds in diabetic animals.

Radha Moorthy1, K M Prabhu, P S Murthy.   

Abstract

Mechanism of action of GII (100 mg/kg body weight, po for 15 days) purified from fenugreek (T. foenum-graecum) seeds was studied in the sub-diabetic and moderately diabetic rabbits. In the sub-diabetic rabbits it did not change much the content of total lipids, glycogen and proteins in the liver, muscle and heart (glycogen was not studied in the heart). However, in the moderately diabetic rabbits same treatment decreased total lipids more in the liver (21%) than those in the heart and muscle. Total protein content increased (14%) in the liver but negligible change (5-7%) was observed in heart and muscle. Glycogen increased (17%) in the liver but not in the muscle of the moderately diabetic rabbits (glycogen was not estimated in the heart). Among the enzymes of glycolysis, activity of glucokinase was not affected in the liver of both the sub-diabetic and moderately diabetic rabbits. Phosphofructokinase and pyruvate kinase activity in both sub-diabetic and moderately diabetic rabbits increased (13-50%) indicating stimulation of glycolysis. The activity of gluconeogenic enzymes glucose-6-phosphatase and fructose-1,6-diphosphatase of the sub-diabetic rabbits decreased in the liver (15-20%) but not in the kidneys. In the moderately diabetic rabbits after treatment with GII, glucokinase in the liver was not affected much (-9%) but increased well in the muscle (40%). Phosphofructokinase and pyruvate kinase were moderately increased both in the liver and the muscle (18-23%). The gluconeogenic enzyme glucose-6-phosphatase decreased reasonably well in the liver and kidneys (22, 32%). Fructose-1,6-diphosphatase decreased only slightly (10, 9%) in the moderately diabetic rabbits. Thus GII seems to decrease lipid content of liver and stimulate the enzymes of glycolysis (except glucokinase) and inhibit enzymes of gluconeogenesis in the liver of the diabetic especially moderately diabetic rabbits.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21117452

Source DB:  PubMed          Journal:  Indian J Exp Biol        ISSN: 0019-5189            Impact factor:   0.818


  7 in total

1.  Mechanism of Antidiabetic Action of Compound GII Purified from Fenugreek (Trigonella foenum graecum) Seeds.

Authors:  D Puri; K M Prabhu; G Dev; S Agarwal; P S Murthy
Journal:  Indian J Clin Biochem       Date:  2011-09-20

2.  Methanolic Fenugreek Seed Extract Induces p53-Dependent Mitotic Catastrophe in Breast Cancer Cells, Leading to Apoptosis.

Authors:  Faris A Alrumaihi; Masood A Khan; Khaled S Allemailem; Mohammed A Alsahli; Ahmad Almatroudi; Hina Younus; Sultan A Alsuhaibani; Mohammad Algahtani; Arif Khan
Journal:  J Inflamm Res       Date:  2021-04-16

3.  An overview of the evidence and mechanisms of herb-drug interactions.

Authors:  Pius S Fasinu; Patrick J Bouic; Bernd Rosenkranz
Journal:  Front Pharmacol       Date:  2012-04-30       Impact factor: 5.810

4.  Inhibition of key digestive enzymes related to diabetes and hyperlipidemia and protection of liver-kidney functions by trigonelline in diabetic rats.

Authors:  Khaled Hamden; Kais Mnafgui; Zahra Amri; Ahmed Aloulou; Abdelfattah Elfeki
Journal:  Sci Pharm       Date:  2012-12-20

Review 5.  Herbal Drugs from Sudan: Traditional Uses and Phytoconstituents.

Authors:  Mohamed Gamaleldin Elsadig Karar; Nikolai Kuhnert
Journal:  Pharmacogn Rev       Date:  2017 Jul-Dec

6.  A novel botanical formula prevents diabetes by improving insulin resistance.

Authors:  Juntao Kan; Rodney A Velliquette; Kerry Grann; Charlie R Burns; Jeff Scholten; Feng Tian; Qi Zhang; Min Gui
Journal:  BMC Complement Altern Med       Date:  2017-07-05       Impact factor: 3.659

7.  Evaluating the effect of a herb on the control of blood glucose and insulin-resistance in patients with advanced type 2 diabetes (a double-blind clinical trial).

Authors:  Mahmoud Parham; Mohammad Bagherzadeh; Majid Asghari; Hossein Akbari; Zahra Hosseini; Maryam Rafiee; Jamshid Vafaeimanesh
Journal:  Caspian J Intern Med       Date:  2020
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.